Semaglutide's Hidden Toll: Unpacking the Unintended Consequences of Weight Loss Medication The rapid ascent of semaglutide, initially approved for type 2 diabetes treatment, into the weight loss market has been meteoric.
Since its FDA approval for chronic weight management in 2021, demand has surged, but a less well known consequence is the significant increase in preventable poison control calls.
Researchers from the University of Texas at San Antonio have found that thousands of people have turned to poison control centers due to accidental dosing mistakes rather than intentional misuse.